its a pathway to a healthier, more vibrant life
You may ask yourself, why am I not losing weight on semaglutide or tirzepatide? Youre not alone
Several important considerations apply: Individuals with active or severe gastrointestinal disease may experience worsening symptoms due to the gastrointestinal side effects of GLP-1 medications The slowed gastric emptying caused by these drugs could theoretically exacerbate symptoms in people with strictures or obstructive complications of Crohn's disease Weight loss associated with GLP-1 therapy may be inappropriate in patients with Crohn's disease who are already experiencing malnutrition or unintentional weight loss The interaction between GLP-1 medications and the inflammatory processes in IBD is not fully understood Clinical decision-making should involve a thorough assessment of disease activity, nutritional status, presence of complications (such as strictures or fistulas), and the primary indication for GLP-1 therapy
Because this is a once-weekly combination, accuracy, rotation and a consistent dosing day matter more than speed
Retatrutide holds no MHRA or EMA marketing authorisation as of 2026
Eat more protein: Protein is a macronutrient that makes you feel full, and can lead to less hunger